Table 3:
Meta-analysis | Other Studies | |||||||
---|---|---|---|---|---|---|---|---|
Study | Domenici et al, 201631 | Kranjcec et al, 20148 | Porru et al, 201437 | Genovese et al, 201738 | Phe et al, 201732 | Del Popolo et al, 201816 | Efros et al, 201030 | Marchiori et al, 201730 |
Definition of recurrent UTI used by each study | ||||||||
≥2 UTI/6 mo and/or ≥3 UTI/12 mo (Sx + Ucx) | • | • | • | • | • | • | ||
≥2 UTI/12 mo (+ Ucx) | • | |||||||
Not reported | • | |||||||
Definition of incident UTI during study follow up | ||||||||
+Sx (no UCx, or not reported) | • | |||||||
+ Sx and Ucx | • | • | • | • | • | • | ||
Not reported/Not evaluated | • | |||||||
Definition of study follow up time | ||||||||
16 weeks | • | • | ||||||
6 months | • | • | • | |||||
24 weeks | • | |||||||
12 months | • | |||||||
Not reported/Not applicable | • |
For all studies with UCx, definition of positive urine culture ranged from ≥103 to ≥105
Abbreviations: UTI, urinary tract infection; UCx, urine culture; Sx, lower urinary tract symptoms; mo, months